[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [$espr](/topic/$espr) ### Top Social Posts *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "$ESPR Management insisted the cash runway was solidclearly not. Lack of transparency is business as usual for this team. Either it was a poison pill to block a takeover or once the offering killed it they chose litigation instead" [X Link](https://x.com/Blueeee_Jay/status/1979291929968853341) [@Blueeee_Jay](/creator/x/Blueeee_Jay) 2025-10-17T21:02Z XXX followers, XXX engagements "$ESPR Sober Reflections Without Drama But Worth Considering These thoughts are prompted by several recent developments. On September XX 2025 BA received approval in Japan. According to the agreement Otsuka were to pay $XX million jupon first JNDA and up to $XX million upon achivement events "MACE" (see screenshot and details pricing-related milestones following inclusion on the NHI list). The payment timeline for these milestones is typically XX months after the event which implies a latest due date around November XX. Then we received the encouraging news about the Dr. Reddys settlement" [X Link](https://x.com/AndriiMart1/status/1979277291416097023) [@AndriiMart1](/creator/x/AndriiMart1) 2025-10-17T20:04Z XX followers, 1136 engagements "$ESPR soaked up the new share offering better than anticipated. Looks like we bump up against $XXXX -$3.50 once or twice more. Then run towards $XXXX. The stock is re-rating before our eyes" [X Link](https://x.com/Bbrc424864Bbrc/status/1979272042513142204) [@Bbrc424864Bbrc](/creator/x/Bbrc424864Bbrc) 2025-10-17T19:43Z XXX followers, XXX engagements "$ESPR $XBI ESPR starts selection ACLY for rare liver condition with potential Orphan Drug Status but more near term catalysts. As mentioned with past posts the new uptrend has started despite market instability. It is safe extremely undervalued" [X Link](https://x.com/MACROVET888/status/1979190924778283279) [@MACROVET888](/creator/x/MACROVET888) 2025-10-17T14:21Z XXX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$ESPR Management insisted the cash runway was solidclearly not. Lack of transparency is business as usual for this team. Either it was a poison pill to block a takeover or once the offering killed it they chose litigation instead"
X Link @Blueeee_Jay 2025-10-17T21:02Z XXX followers, XXX engagements
"$ESPR Sober Reflections Without Drama But Worth Considering These thoughts are prompted by several recent developments. On September XX 2025 BA received approval in Japan. According to the agreement Otsuka were to pay $XX million jupon first JNDA and up to $XX million upon achivement events "MACE" (see screenshot and details pricing-related milestones following inclusion on the NHI list). The payment timeline for these milestones is typically XX months after the event which implies a latest due date around November XX. Then we received the encouraging news about the Dr. Reddys settlement"
X Link @AndriiMart1 2025-10-17T20:04Z XX followers, 1136 engagements
"$ESPR soaked up the new share offering better than anticipated. Looks like we bump up against $XXXX -$3.50 once or twice more. Then run towards $XXXX. The stock is re-rating before our eyes"
X Link @Bbrc424864Bbrc 2025-10-17T19:43Z XXX followers, XXX engagements
"$ESPR $XBI ESPR starts selection ACLY for rare liver condition with potential Orphan Drug Status but more near term catalysts. As mentioned with past posts the new uptrend has started despite market instability. It is safe extremely undervalued"
X Link @MACROVET888 2025-10-17T14:21Z XXX followers, XXX engagements
/topic/$espr/posts